Article Information
PubMed
Published By
Online ISSN
History
- Received April 27, 2023
- Revision received August 6, 2023
- Accepted August 7, 2023
- Published online August 21, 2023.
Copyright & Usage
© 2023 Zhong et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Hui Zhong1,3,*, Validation, Methodology,
- Ran Zhang1,2,4,*, Resources, Validation, Methodology, Project administration,
- Guihuan Li2,*, Resources, Validation,
- Ping Huang9, Resources, Validation,
- Yudan Zhang4, Resources, Validation,
- Jieying Zhu3, Resources, Validation,
- Junqi Kuang5, Resources,
- Andrew P Hutchins6, Resources,
- Dajiang Qin2,4,8, Resources, Funding acquisition⇑,
- Ping Zhu1,7, Funding acquisition,
- Duanqing Pei5, Funding acquisition⇑ and
- Dongwei Li1,2, Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing⇑
- 1Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
- 2Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
- 3CAS Key Laboratory of Regenerative Biology, Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
- 4Bioland Laboratory Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China
- 5Laboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China
- 6Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China
- 7Guangdong Provincial Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease and Guangzhou Key Laboratory of Pathogenesis, Targeted Prevention and Treatment of Heart Disease, Guangzhou, China
- 8Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences; Hong Kong, China
- 9The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, P.R. China
- Correspondence: tanganqier{at}163.com
- peiduanqing{at}westlake.edu.cn
- lidongwei{at}gzhmu.edu.cn
↵* Hui Zhong, Ran Zhang, and Guihuan Li are Co-first authors
Funding
National Natural Science Foundation of China
92068021D LiMOST | National Natural Science Foundation of China (NSFC)
32270574D LiMOST | National Natural Science Foundation of China (NSFC)
32150710521D PeiNational Key Research and Development Program of China
2018YFA0108700; 2017YFA0105602D LiGuangdong Science and Technology Project
2020B1212060052; 2022B1212010010D LiScience and Technology Projects in Guangzhou
2023A03J0045; 2023A04J0156D LiGuangzhou Key Laboratory of Biological Targeting Diagnosis and Therapy
202201020379D LiYouth Innovation Promotion of the Chinese Academy of Sciences
2019348D LiGuangdong Cardiovascular Institute
2020XXG002D LiHigh-level Hospital Construction Project
DFJHBF202110; DFJHBF202111
In this Issue
Advertisement
Subjects
Related Articles
Cited By...
- No citing articles found.